UBS O'Connor’s DTRT Health Acquisition Corp. Class A Common Stock DTRT Stock Holding History

UBS O'Connor’s Portfolio DTRT Stock Details DTRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-240,341	Closed	-$2.49M	–	858
2022 Q4	$2.49M	Sell	240,341 -2,952	-1%	-$30.2K	0.05%	351
2022 Q3	$2.47M	Sell	243,293 -24,356	-9%	-$246K	0.03%	501
2022 Q2	$2.69M	Hold	267,649	–	–	0.03%	491
2022 Q1	$2.69M	Buy	267,649 +4,717	+2%	+$47.1K	0.03%	448
2021 Q4	$2.64M	Buy	+262,932	New	+$2.62M	0.03%	429

UBS O'Connor's DTRT Position: Q1 2023 in Review

UBS O'Connor sold out of DTRT Health Acquisition Corp. Class A Common Stock (DTRT) in Q1 2023, closing a stake of 240,341 shares — an estimated $2.49M sold.

UBS O'Connor first reported a position in DTRT in Q4 2021 and held it in 5 quarters. The position peaked at $2.69M in Q2 2022. 0 funds tracked by Wall St. Rank hold DTRT as of Q1 2023.

UBS O'Connor reported no remaining DTRT Health Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
UBS O'Connor sold 240,341 DTRT Health Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $2.49M.
UBS O'Connor first reported a position in DTRT Health Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 5 quarters.
UBS O'Connor's DTRT Health Acquisition Corp. Class A Common Stock position peaked at $2.69M in Q2 2022.
0 funds tracked by Wall St. Rank held DTRT Health Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.